LLY vs NVO: Stock Comparison

Eli Lilly and Company (LLY) has a market cap of $1.21T and Novo Nordisk A/S (NVO) has a market cap of $169.61B. The trailing P/E is 43.03 for LLY and 1.46 for NVO. The 1-year total return is +56.10% for LLY and -25.95% for NVO.

See LLYSee NVO

Key metrics

MetricLLYNVO
Price$1,287.82$38.45
Market cap$1.21T$169.61B
P/E43.031.46
Revenue growth+44.70%+6.43%
Operating margin+49.72%+43.13%
Dividend yield0.52%4.67%
1-year total return+56.10%-25.95%
3-year total return+133.59%-56.45%
5-year total return+436.25%-20.81%

Performance

Total return (%)

0.0%+200%+400%Oct 2021Jun 2023Feb 2025Oct 2026

Date

LLYNVO

Total return from Oct 8, 2021 to Oct 27, 2026, rebased to the first date.

Which is better for...

  • Income. NVO yields more, at 4.67% versus 0.52% for LLY.
  • The past year. LLY returned more, at +56.10% versus -25.95% for NVO.
  • Valuation. NVO has the lower trailing P/E, at 1.46 versus 43.03 for LLY.
  • Growth. LLY has faster revenue growth, at +44.70% versus +6.43% for NVO.
  • The past five years. LLY returned more, at +436.25% versus -20.81% for NVO.

These lines restate the figures above. They are not a recommendation.

Frequently asked questions

What is the market cap of LLY vs NVO?

Eli Lilly and Company (LLY) has a market cap of $1.21T. Novo Nordisk A/S (NVO) has a market cap of $169.61B.

How did LLY and NVO perform over the past year?

The 1-year total return is +56.10% for LLY and -25.95% for NVO.

Which has the higher dividend yield, LLY or NVO?

LLY's dividend yield is 0.52%. NVO's dividend yield is 4.67%.

What is the 5-year total return of LLY vs NVO?

The 5-year total return is +436.25% for LLY and -20.81% for NVO.

Is this comparison investment advice?

No. This page reports published figures for LLY and NVO. It is not a recommendation.

Compare other stocks